0001906425-25-000004.txt : 20251210 0001906425-25-000004.hdr.sgml : 20251210 20251209200514 ACCESSION NUMBER: 0001906425-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251210 DATE AS OF CHANGE: 20251209 EFFECTIVENESS DATE: 20251210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Invea Therapeutics, Inc CENTRAL INDEX KEY: 0001906425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 873198325 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-566314 FILM NUMBER: 251560555 BUSINESS ADDRESS: STREET 1: 2614 BOSTON POST ROAD, #33A CITY: GUILFORD STATE: CT ZIP: 06437 BUSINESS PHONE: 203-204-6363 MAIL ADDRESS: STREET 1: 2614 BOSTON POST ROAD, #33A CITY: GUILFORD STATE: CT ZIP: 06437 D 1 primary_doc.xml X0708 D LIVE 0001906425 Invea Therapeutics, Inc 2614 BOSTON POST ROAD, SUITE 33B GUILFORD CT CONNECTICUT 06437 (203) 643-8002 DELAWARE None None Corporation true 2021 Krishnan Nandabalan 2614 Boston Post Road, Suite 33B Guilford CT CONNECTICUT 06437 Executive Officer Director Chief Executive Officer and Chairman Aman Kant 2614 Boston Post Road, Suite 33B Guilford CT CONNECTICUT 06437 Executive Officer President Michael J. Aiello 2614 Boston Post Road, Suite 33B Guilford CT CONNECTICUT 06437 Executive Officer Chief Financial Officer Salvatore Alesci 2614 Boston Post Road, Suite 33B Guilford CT CONNECTICUT 06437 Executive Officer Chief Scientific Officer Shunichiro "Steve" Okada 2614 Boston Post Road, Suite 33B Guilford CT CONNECTICUT 06437 Executive Officer Chief Medical Officer Kerrie Brady 2614 Boston Post Road, Suite 33B Guilford CT CONNECTICUT 06437 Director Stephen Doberstein 2614 Boston Post Road, Suite 33B Guilford CT CONNECTICUT 06437 Director Demetrios Kydonieus 2614 Boston Post Road, Suite 33B Guilford CT CONNECTICUT 06437 Director Jonathan Zalevsky 2614 Boston Post Road, Suite 33B Guilford CT CONNECTICUT 06437 Director Biotechnology Decline to Disclose 06b false 2025-10-31 false true true false 10000 120250 120250 0 false 1 0 0 0 false Invea Therapeutics, Inc /s/ Michael J. Aiello Michael J. Aiello Chief Financial Officer 2025-12-09